Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.64K Buy
54
+33
+157% +$2.2K ﹤0.01% 1300
2026
Q1
$1.32K Buy
21
+5
+31% +$348 ﹤0.01% 1377
2025
Q4
$1.06K Buy
16
+9
+129% +$582 ﹤0.01% 1309
2025
Q3
$471 Buy
7
+1
+17% +$79 ﹤0.01% 1448
2025
Q2
$524 Sell
6
-6
-50% -$470 ﹤0.01% 1335
2025
Q1
$819 Buy
+12
New +$979 ﹤0.01% 1206
2024
Q3
Sell
-100
Closed -$11.3K 1136
2024
Q2
$11.3K Buy
+100
New +$12.6K ﹤0.01% 636
2023
Q1
Sell
-12
Closed -$1.36K 1132
2022
Q4
$1.36K Buy
+12
New +$1.32K ﹤0.01% 830

Other funds holding DXCM

Bogart Wealth LLC's DXCM Position: Q2 2026 in Review

Bogart Wealth LLC increased its DexCom (DXCM) stake by 157% in Q2 2026, buying an estimated $2.2K and bringing the position to 54 shares worth $3.64K. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

Bogart Wealth LLC first reported a position in DXCM in Q4 2022 and has held it in 8 quarters since. The position peaked at $11.3K in Q2 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Bogart Wealth LLC held 54 shares of DexCom worth $3.64K as of Q2 2026.
  • Bogart Wealth LLC bought 33 DexCom shares in Q2 2026, an estimated $2.2K.
  • DexCom made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1300 holding.
  • Bogart Wealth LLC first reported a position in DexCom in Q4 2022 and has held it in 8 quarters since.
  • Bogart Wealth LLC's DexCom position peaked at $11.3K in Q2 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.